M&T Bank’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
6,912
+2,213
+47% +$241K ﹤0.01% 886
2026
Q1
$434K Sell
4,699
-419
-8% -$42.1K ﹤0.01% 1197
2025
Q4
$523K Buy
+5,118
New +$458K ﹤0.01% 1105
2022
Q4
– Sell
-3,721
Closed -$202K – 1636
2022
Q3
$202K Buy
+3,721
New +$191K ﹤0.01% 1425
2022
Q2
– Sell
-4,112
Closed -$272K – 1666
2022
Q1
$272K Buy
4,112
+1,459
+55% +$99.8K ﹤0.01% 1246
2021
Q4
$266K Buy
2,653
+85
+3% +$8.79K ﹤0.01% 1301
2021
Q3
$321K Sell
2,568
-302
-11% -$35.9K ﹤0.01% 1201
2021
Q2
$356K Buy
2,870
+231
+9% +$31.1K ﹤0.01% 1188
2021
Q1
$402K Sell
2,639
-3,483
-57% -$526K ﹤0.01% 1096
2020
Q4
$789K Buy
6,122
+261
+4% +$30K ﹤0.01% 857
2020
Q3
$656K Buy
5,861
+1,376
+31% +$126K ﹤0.01% 854
2020
Q2
$363K Buy
4,485
+1,029
+30% +$82.9K ﹤0.01% 1099
2020
Q1
$241K Buy
+3,456
New +$265K ﹤0.01% 1248

Other funds holding GH

M&T Bank's GH Position: Q2 2026 in Review

M&T Bank increased its Guardant Health (GH) stake by 47% in Q2 2026, buying an estimated $241K and bringing the position to 6,912 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #886.

M&T Bank first reported a position in GH in Q1 2020 and has held it in 13 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • M&T Bank held 6,912 shares of Guardant Health worth $1.04M as of Q2 2026.
  • M&T Bank bought 2,213 Guardant Health shares in Q2 2026, an estimated $241K.
  • Guardant Health made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #886 holding.
  • M&T Bank first reported a position in Guardant Health in Q1 2020 and has held it in 13 quarters since.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.